1.90

1.55% -0.03

Vyome Holdings Inc (HIND)

Overview News Price History Financials Discussions Forecast Stock Split

Vyome Holdings Inc stock is traded at $1.90, with a volume of 13,529. It is down -1.55% in the last 24 hours and down -5.47% over the past month. Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Previous Close:

$1.93

Open:

$1.9179

24h Volume:

13,529

Relative Volume:

1.31

Market Cap:

$13.34M

Revenue:

$1.34M

Net Income/Loss:

$-13.49M

P/E Ratio:

-0.1531

EPS:

-12.4093

Net Cash Flow:

$-3.07M

1W Performance:

-6.40%

1M Performance:

-5.47%

6M Performance:

-15.18%

1Y Performance:

-64.35%

1-Day Range:

$1.83

$1.9299

1-Week Range:

$1.91

$2.09

52-Week Range:

$1.75

$6.56

Vyome Holdings Inc Stock (HIND) Company Profile

Name

Vyome Holdings Inc

Sector

Healthcare (1051)

Industry

Biotechnology (593)

Phone

949-429-6680

Address

1001 CALLE AMANECER, SAN CLEMENTE

Employee

Twitter

Next Earnings Date

2026-11-13

Latest SEC Filings

HIND's Discussions on Twitter

Compare HIND vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HIND Vyome Holdings Inc	1.90	13.34M	1.34M	-13.49M	-3.07M	-12.41
VRTX Vertex Pharmaceuticals Inc	508.46	128.88B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	237.99	95.01B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	800.59	82.42B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	849.61	53.43B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	372.06	42.09B	5.76B	514.49M	1.10B	4.4813

Vyome Holdings Inc Stock (HIND) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-03-26	Initiated	Chardan Capital Markets	Buy

Vyome Holdings Inc Stock (HIND) Latest News

Sep 03, 2026

Price to earnings forward of Vyome Holdings, Inc. – GETTEX:H1O - TradingView

Sep 03, 2026

Sep 02, 2026

Vyome Holdings CFO Leonard Jerry Listed in Latest SEC Insider Filing - Kalkine Media

Sep 02, 2026

Aug 29, 2026

Vyome Holdings Appoints Consulting CFO Jerry Leonard - The Globe and Mail

Aug 29, 2026

Aug 28, 2026

Vyome Holdings, Inc. Appoints Jerry Leonard as Principal Financial Officer and Principal Accounting Officer, Effective September 1, 2026 - marketscreener.com

Aug 28, 2026

Aug 25, 2026

Vyome Holdings (HIND) advances VT-1953, carries no debt - Stock Titan

Aug 25, 2026

Vyome's wound gel reduced bad odor and improved lesion pain in statistically significant Phase 2 data - Stock Titan

Aug 25, 2026

Vyome Reports $720,000 Second-Quarter Net Loss as VT-1953 Program Advances - Quiver Quantitative

Aug 25, 2026

Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet - Yahoo Finance

Aug 25, 2026

Aug 20, 2026

Vyome Holdings, Inc. (NASDAQ: HIND) Share Price, HIND Stock News, HIND Share Price & Updates - Kalkine

Aug 20, 2026

Aug 19, 2026

Vyome (HIND) Move: Records a 1.77% Increase to $2.31 on the Day; the Near-Term Reference Band Stretches From $2.19 to $2.43 in the Current UpdateSuperTrend - vinanet.vn

Aug 19, 2026

Aug 17, 2026

Vyome Holdings, Inc. (NASDAQ: HIND) Share Price, HIND Stock News, HIND Share Price & Updates - kalkine.ca

Aug 17, 2026

HIND Q2 2026 Earnings: Narrower-than-Expected Loss Delivers 48.4% EPS BeatForward EPS Estimate - vinanet.vn

Aug 17, 2026

Aug 15, 2026

Vyome Holdings (HIND) Advances 0.93% to $2.18, Approaching Resistance at $2.29Wyckoff Accumulation - vinanet.vn

Aug 15, 2026

Aug 12, 2026

VYOME HOLDINGS ($HIND) Releases Q2 2026 Earnings - Quiver Quantitative

Aug 12, 2026

Vyome Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 12, 2026

Vyome Holdings (HIND) Edges Lower: Stock Testing Support Near $2.11KAMA Signal - Vinanet

Aug 12, 2026

Vyome Holdings (HIND) posts higher H1 2026 loss as R&D spending grows - Stock Titan

Aug 12, 2026

Vyome Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 12, 2026

Aug 10, 2026

Vyome Holdings Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView

Aug 10, 2026

Aug 07, 2026

HIND Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SentimentEPS Surprise History - vinanet.vn

Aug 07, 2026

Aug 06, 2026

HIND Q2'26 Earnings: EPS estimate is (0.19) USD - TradingView

Aug 06, 2026

Aug 05, 2026

Vyome Holdings Ord Shs (HIND) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 05, 2026

Jul 27, 2026

Vyome Holdings, Inc. Revenue Breakdown – NASDAQ:HIND - TradingView

Jul 27, 2026

Jul 26, 2026

Vyome Holdings (HIND) Slides 2.37%: Support and Resistance Levels in FocusSafe Entry Stocks - dars.gov.et

Jul 26, 2026

Vyome Holdings Ord Shs (HIND) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 26, 2026

Vyome Holdings (HIND) Slides 2.37%: Support and Resistance Levels in FocusHedge Fund Exposure - vinanet.vn

Jul 26, 2026

HIND|Vyome Holdings Ord Shs|Price:2.060|Chg%:-0.080 - TradingKey

Jul 26, 2026

Jul 25, 2026

HIND|Vyome Holdings Ord Shs|Price:1.990|Chg%:-0.010 - TradingKey

Jul 25, 2026

Jul 24, 2026

Vyome Holdings (HIND) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesWeak Earnings Momentum - vinanet.vn

Jul 24, 2026

Jul 23, 2026

HIND Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Improved Cost DisciplineTech Earnings Analysis - vinanet.vn

Jul 23, 2026

Jul 22, 2026

Price to sales forward of Vyome Holdings, Inc. – NASDAQ:HIND - TradingView

Jul 22, 2026

Jul 20, 2026

HIND Q1 2026 Earnings: EPS Beat Estimates as Cost Management Drives SurpriseEarnings Analysis - vinanet.vn

Jul 20, 2026

Jul 19, 2026